Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 7, 2021
A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in ChinaLianzhong Wu, Jin Lai, Yixin Ling, et al.Journal for Immunotherapy of Cancer|May 14, 2021
Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activationShujuan Zhou, Fanyan Meng, Shiyao Du, et al.Frontiers in Oncology|December 6, 2023
TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trialJuefeng Wan, Ruiyan Wu, Miaomiao Fu, et al.Bioengineering & Translational Medicine|November 29, 2023
Membrane fusogenic nanoparticle-based HLA-peptide-addressing universal T cell receptor-engineered T (HAUL TCR-T) cell therapy in solid tumorRuihan Xu, Qin Wang, Junmeng Zhu, et al.Therapeutic Advances in Hematology|January 30, 2026
The impact of clinical manifestations on the prognosis of diffuse large B-cell lymphomaSiqian Wang, Xi Xu, Yongyong Ma, et al.Clinical Therapeutics|August 8, 2025
Pegylated Liposomal Doxorubicin Confers a High Risk for Pneumocystis Jirovecii Pneumonia in Patients With Diffuse Large B-Cell LymphomaSiqian Wang, Xi Xu, Yongyong Ma, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|November 2, 2023
Identification of pneumococcal serotypes with individual recognition of vaccine types by a highly multiplexed real-time PCR-based MeltArray approachShujuan Zhou, Jie Che, Xuran Wang, et al.Oncotargets and Therapy|December 10, 2019
Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric CancerJu Yang, Jing Yan, Jie Shao, et al.Oncotarget|January 21, 2017
Peripheral blood lymphocyte to monocyte ratio recovery from low levels at diagnosis after completion of first line therapy predicts good clinical outcomes in patients with diffuse large B-cell lymphomaShujuan Zhou, Linglong Xu, Yongyong Ma, et al.Journal of Experimental & Clinical Cancer Research : CR|April 4, 2023
Newly developed 3D in vitro models to study tumor-immune interactionPeiyuan Mu, Shujuan Zhou, Tao Lv, et al.Pageof 6